Sana Biotechnology, Inc. (SANA)
Engineers cells to replace or repair damaged organs and tissues in the body.
$3.29+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-15.9%
The outlook
SANA is trading near its 52-week low, with the stock positioned in the bottom quarter of its recent range. Analyst sentiment remains mixed overall, though the average price target sits about 161% above the current level. The stock lacks a clear directional trend at present.
What’s behind the score
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +161% vs current price
Analyst price target
~12-month · 7 analysts$8.57average target+160.5% vs now
Now $3.29
Low $7.00High $12.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$915.6M
52-wk high
$6.55
52-wk low
$2.61
50-day avg
$3.24
200-day avg
$3.85
Trailing P/E
—